Browse grants

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of Defense (CDMRP) Alzheimer's Research Program Transforming Research Award funds non-incremental research on reducing risk and preventing Alzheimer's disease and related dementias, focused on risk factor knowledge or risk reduction solutions. Eligibility is described as unrestricted (open to any eligible entity type), subject to clarifications in the announcement. Clinical research is allowed but clinical trials and animal research are prohibited, preliminary data are required, and community collaboration is required when prospectively enrolling human subjects. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of Defense (CDMRP) Alzheimer's Research Program Transforming Diagnosis Award funds solutions-oriented research that reduces barriers to diagnosis, disease monitoring, and prognosis for Alzheimer's disease and related dementias. Eligibility is described as unrestricted (open to any eligible entity type), subject to clarifications in the announcement. Clinical research is allowed but clinical trials and animal research are prohibited, preliminary data are required, and community collaboration is required when prospectively enrolling human subjects. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of Defense (CDMRP) Alzheimer's Research Program Transforming Care Award funds clinical research and clinical trials evaluating interventions and solutions in dementia care for individuals with Alzheimer's disease and related dementias and their care partners. Eligibility is described as unrestricted (open to any eligible entity type), subject to clarifications in the announcement. Trials solely testing pharmacological interventions and studies using animal models do not meet the intent, preliminary data are required, and community collaboration is required when prospectively enrolling human subjects. No specific award amount is stated.

National Institutes of Health · Up to $350K

This NIH program (S15) helps eligible academic or research institutions buy modern equipment to modernize shared-use biomedical research facilities such as core labs and animal research facilities. Eligible applicants are institutions, including minority-serving institutions, HBCUs, and tribal colleges; foreign organizations and foreign components are not eligible. The award ceiling is about $350,000, and the program does not fund scientific research instruments themselves or building-level infrastructure. This is institution-focused support, not for individuals or general organizations.

National Institutes of Health · Amount varies

This NIH P50 SPORE grant funds translational cancer research centers focused on improving prevention, early detection, diagnosis, and treatment for a specific organ system or related group of cancers. Projects must have a clear path toward a translational human endpoint within the grant period, and it's aimed at eligible U.S. research institutions. The deadline is September 25, 2026.

National Institutes of Health · Amount varies

This NIH T32 institutional training grant funds interdisciplinary predoctoral and postdoctoral training programs on translational Alzheimer's disease and related dementia research, spanning data science, disease biology, and drug discovery. It's aimed at eligible U.S. research institutions (HBCUs and tribal colleges included). The deadline is September 25, 2026.

National Institutes of Health · Amount varies

This NIH limited-competition program (P51) supports the activities of the National Primate Research Centers, which provide nonhuman primate resources to investigators nationally. Because it is a limited competition tied to the existing primate centers, eligibility is narrow; foreign institutions and foreign components are not eligible to apply, and applicants should consult the full announcement for eligibility details. No award amount is stated. This is effectively restricted to organizations operating designated primate research centers, not open to general applicants.

National Institutes of Health · Amount varies

This NIH/ORIP resource award (R24) funds core facilities, resource centers, animal vivaria, or investigators to acquire equipment and study how environmental extrinsic factors affect animal research, aiming to improve rigor and reproducibility. The work must be broadly relevant to two or more NIH Institutes or Centers. Eligible applicants are institutions, including minority-serving institutions, HBCUs, and tribal colleges; foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components are otherwise allowed. No award amount is stated; eligibility centers on research institutions and shared-resource facilities.

National Institutes of Health · Amount varies

This NIH T32 grant funds institutional predoctoral training programs in basic biomedical sciences, supporting didactic coursework, research experience, and career development for graduate trainees. It's aimed at eligible U.S. research and training institutions (HBCUs and tribal colleges included). The deadline is September 25, 2026.

National Institutes of Health · Amount varies

This NIH limited-competition program (U42) provides continuing support for specific pathogen-free macaque breeding colonies that supply animals for HIV/AIDS research, building on prior awards. Because it is a limited competition continuing previously funded colonies, eligibility is narrow; foreign organizations and foreign components of U.S. organizations are not eligible, and applicants should see the NOFO for details. No award amount is stated. This is effectively restricted to organizations operating the relevant macaque colonies, not open to general applicants.

National Institutes of Health · Up to $1.3M

This NIH/NCI program (U54) funds Specialized Centers within the Metastasis Research Network to pursue integrative, multidisciplinary basic research on cancer metastasis. Eligible applicants are research institutions, and notably foreign organizations, non-U.S. components of U.S. organizations, and foreign components are all eligible to apply here. The award ceiling is about $1.3M. This is a center-grant mechanism aimed at research institutions, not individuals or general organizations; see the NOFO for full eligibility details.

National Institutes of Health · Amount varies

This NIH R24 grant funds non-hypothesis-driven resources, such as data, materials, tools, or services, that support the broader alcohol research community, provided they don't duplicate existing commercial or other resources. It's aimed at eligible U.S. research institutions; foreign organizations are not eligible. The deadline is September 25, 2026.

National Institutes of Health · Amount varies

This NIH P01 Program Project Grant funds collaborative, multi-project research (a minimum of three interrelated projects) on heart, lung, blood, and sleep-related diseases, including implementation science and health disparities work. It's aimed at eligible U.S. research institutions and is particularly interested in new scientific directions and early-stage investigator-led projects. The deadline is September 25, 2026.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of Defense (CDMRP) Kidney Cancer Research Program Idea Development Award funds high-impact, hypothesis-driven research that advances understanding of kidney cancer and aims to improve patient outcomes. Eligibility is described as unrestricted (open to any eligible entity type), subject to clarifications in the announcement, and a partnering PI option supports two-investigator collaborations. Project teams are expected to have a strong kidney cancer research background. No specific award amount is stated.

National Institutes of Health · Up to $400K

This NIH R25 grant (up to $400,000) funds institutional programs that engage grades 6-12 and undergraduate students, and their teachers or faculty, in hands-on cancer research experiences to build interest in biomedical research careers. It's aimed at eligible U.S. institutions; foreign organizations are not eligible. The deadline is September 28, 2026.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of Defense (CDMRP) Kidney Cancer Research Program Academy of Kidney Cancer Investigators Early-Career Scholar Award supports junior faculty through a virtual academy that pairs early-career scholars with established mentors and emphasizes both research and career development in kidney cancer. Eligibility is described as unrestricted (open to any eligible entity type), subject to clarifications in the announcement, but the award is geared toward early-career investigators. Preliminary data are required, though they need not come from the kidney cancer field. No specific award amount is stated.

U.S. National Science Foundation · $50K–$1.2M

The NSF Security, Privacy, and Trust in Cyberspace (SaTC 2.0) program funds research on the security, privacy, and resilience of cyber systems, spanning technical and social dimensions. Proposals may only be submitted by U.S. institutions of higher education and non-profit, non-academic research organizations; PIs must hold qualifying academic or research appointments, and individuals at for-profit organizations or overseas branch campuses are not eligible. Awards range from about $50,000 to $1.2M. Eligibility is restricted to higher-education and nonprofit research organizations.

National Institutes of Health · Amount varies

This NIH RC2 opportunity is a limited competition open only to institutions already holding a UM1 Clinical and Translational Science Award (CTSA) Hub grant, funding development of specialized research platforms and capabilities to address gaps in clinical and translational science. It is not open to applicants outside the existing CTSA Hub network. The deadline is September 28, 2026.

National Institutes of Health · Amount varies

This NIH BRAIN Initiative program (UG3/UH3) is a milestone-driven cooperative agreement supporting translational development and small clinical studies of next-generation therapeutic and diagnostic devices for nervous and neuromuscular disorders. Eligible applicants are institutions, including minority-serving institutions, HBCUs, and tribal colleges; foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components are otherwise allowed. NIH program staff participate in project planning and monitoring. No award amount is stated; eligibility centers on research institutions able to develop and test devices.

National Institutes of Health · Amount varies

This NIH BRAIN Initiative program (UH3) funds small clinical trials to advance next-generation devices for recording and modulating the human central nervous system. Eligible applicants are institutions, including minority-serving institutions, HBCUs, and tribal colleges; foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components are otherwise allowed. No award amount is stated. This is a clinical-research mechanism aimed at research institutions capable of conducting device trials.